News
DeepHow introduces PharmaCloud for pharmaceutical manufacturers
3+ hour, 28+ min ago (121+ words) The new solution is intended for pharmaceutical and medical device manufacturers, enabling them to train operators, guide execution, and verify critical tasks using advanced AI-technologies. Manufacturers can utilise AI to document expert knowledge, guide workers through standardised procedures, and verify…...
JPM26: Illumina debuts Billion Cell Atlas to drive AI-driven drug discovery
6+ day, 20+ hour ago (295+ words) The Billion Cell Atlas, backed by Eli Lilly, MSD and AstraZeneca, maps mechanisms to support informed drug discovery. In a move away from its core focus on DNA sequencing technology, San Diego-based biotech Illumina has debuted a genetic dataset designed…...
JPM26: Eli Lilly and NVIDIA deepen ties with $1bn AI partnership
1+ week, 20+ hour ago (323+ words) A new co-innovation lab in the San Francisco Bay area will see Lilly and NVIDIA scientists work alongside each other to fuel drug discovery improvements. Eli Lilly and NVIDIA will establish a new artificial intelligence (AI) co-innovation lab, as the…...
Exploring AI-powered cell simulations and the launch of the world’s first virtual lab
5+ mon, 3+ week ago (710+ words) In 2025, Turbine took the first steps in opening its powerful cell simulation platform to the wider drug development community, and researchers working in the antibody-drug conjugate space are the first to benefit. In Association with Turbine Artificial intelligence and machine…...
How AI and machine learning are transforming drug discovery
6+ mon, 3+ week ago (229+ words) In Association with Veradigm Drug discovery has traditionally been slow, time-consuming, expensive and prone to failure, but AI and machine learning are set to change all that. AI is revolutionizing drug discovery with its ability to analyze vast datasets. Particularly…...